ADWISPO
LIVE

Serial Number

99042193

Owner

Bristol-Myers Squibb Company

Attorney

Xiomara Triana

Filing Date

Feb 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ADWISPO Trademark

Serial Number: 99042193

ADWISPO is a trademark filed by Bristol-Myers Squibb Company on February 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bristol-Myers Squibb Company (65 trademarks)

Route 206 & Province Line Road
Princeton, NJ 08543

Entity Type: 03

Trademark Details

Filing Date

February 14, 2025

Registration Date

Not Registered

Published for Opposition

December 16, 2025

Goods & Services

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; antivirals; antibodies for medical purposes; biological preparations for the treatment of cancer; anticoagulants; stem cells for medical purposes; radio-pharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radio-pharmaceutical preparations; diagnostic preparations for medical purposes

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 10, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2025 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 23, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 23, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jul 23, 2025 CNSL
ASSIGNED TO EXAMINER
Jul 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 14, 2025 MAFR
NEW APPLICATION ENTERED
Feb 14, 2025 NWAP